These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36308710)
41. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G; Runkel S; Zdunek D; Hitzler WE Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172 [TBL] [Abstract][Full Text] [Related]
42. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921 [TBL] [Abstract][Full Text] [Related]
43. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study. Prontera C; Zaninotto M; Giovannini S; Zucchelli GC; Pilo A; Sciacovelli L; Plebani M; Clerico A Clin Chem Lab Med; 2009; 47(6):762-8. PubMed ID: 19402791 [TBL] [Abstract][Full Text] [Related]
44. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
45. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure. Farnsworth CW; Bailey AL; Jaffe AS; Scott MG Clin Biochem; 2018 Sep; 59():50-55. PubMed ID: 30111510 [TBL] [Abstract][Full Text] [Related]
46. Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system. Cauliez B; Guignery J; Marinier S; Mariau I; Lavoinne A Ann Clin Biochem; 2008 May; 45(Pt 3):318-9. PubMed ID: 18482923 [TBL] [Abstract][Full Text] [Related]
48. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Fuat A; Murphy JJ; Hungin AP; Curry J; Mehrzad AA; Hetherington A; Johnston JI; Smellie WS; Duffy V; Cawley P Br J Gen Pract; 2006 May; 56(526):327-33. PubMed ID: 16638247 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of analytical performances using standardized analytical protocols and comparison of clinical results of the new ADVIA BNP and NT-proBNP immunoassays for the Centaur XPT platform. Masotti S; Musetti V; Prontera C; Storti S; Ndreu R; Passino C; Zucchelli G; Clerico A Clin Chem Lab Med; 2019 May; 57(6):911-917. PubMed ID: 30412461 [TBL] [Abstract][Full Text] [Related]
50. Interlaboratory variation for NT-proBNP among Swedish laboratories in an external quality program 2011-2021. Lundgren M; Ridefelt P; Karlsson M; Norling A; Larsson A Clin Chem Lab Med; 2023 Aug; 61(9):1643-1651. PubMed ID: 36988017 [TBL] [Abstract][Full Text] [Related]
51. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin. Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724 [TBL] [Abstract][Full Text] [Related]
52. Diagnostic value of circulating microRNA-19b in heart failure. Zhang L; Xu RL; Liu SX; Dong SH; Zhao XX; Zhang BL Eur J Clin Invest; 2020 Nov; 50(11):e13308. PubMed ID: 32663314 [TBL] [Abstract][Full Text] [Related]
53. Analytical and clinical performance of the Ortho-Clinical Diagnostics VITROS amino-terminal pro-B type natriuretic peptide assay. Januzzi JL; Lewandrowski KB; Bashirians G; Jackson S; Freyler D; Smith K; Murakami MM; Apple FS Clin Chim Acta; 2008 Jan; 387(1-2):48-54. PubMed ID: 17915201 [TBL] [Abstract][Full Text] [Related]
54. NT-proBNP in monitoring treatment of patients with congestive heart failure. Al-Meslmani BM; Fahoum SK; Shamia MG Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823 [TBL] [Abstract][Full Text] [Related]
55. Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure. Bellagambi FG; Petersen C; Salvo P; Ghimenti S; Franzini M; Biagini D; Hangouët M; Trivella MG; Di Francesco F; Paolicchi A; Errachid A; Fuoco R; Lomonaco T Sci Rep; 2021 Jun; 11(1):13088. PubMed ID: 34158583 [TBL] [Abstract][Full Text] [Related]
56. Development and calibration of a new point-of-care test for the determination of NT-proBNP in whole blood. Bertsch T; Dikkeschei B; Gurr E; Hayen W; Jørgensen B; Lotz J; Müller-Bardorff M; Ordóñez-Llanos J; Schulz I; Spinke J; Thiele M; Zerback R Clin Lab; 2007; 53(7-8):423-31. PubMed ID: 17821946 [TBL] [Abstract][Full Text] [Related]
57. Analytical validation of a novel point-of-care immunoassay for canine N-terminal pro-brain natriuretic peptide analysis. Harr KE; Gordon SG; Baumwart RD; Feldgreber R; Spiro MR Vet Clin Pathol; 2022 Sep; 51(3):398-407. PubMed ID: 35312100 [TBL] [Abstract][Full Text] [Related]
58. Analytical performances and heart failure research of the BNP and NT-proBNP assays on the Cobas E601 and ADVIA Centaur. Zhang X; Wang W; Wang Q; Yang Y; Wen D; Yang Z; Lan H; Li F; Ouyang N; Kan L; Suo M; Yan H Clin Lab; 2013; 59(7-8):715-25. PubMed ID: 24133898 [TBL] [Abstract][Full Text] [Related]
59. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
60. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea. Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]